Study to Test Rizatriptan in the Early Treatment of Acute Migraine (0462-081)

PHASE3CompletedINTERVENTIONAL

Enrollment

207

Participants

Timeline

Start Date

October 3, 2007

Primary Completion Date

April 8, 2008

Study Completion Date

April 8, 2008

Conditions

Migraine

Interventions

DRUG

Comparator: rizatriptan benzoate

Rizatriptan 10 mg Orally Disintegrating Tablet (ODT); one dose, treatment of a single migraine attack

DRUG

Comparator: Placebo

Matching placebo; one dose, treatment of a single migraine attack

All Listed Sponsors

lead

Organon and Co

INDUSTRY

NCT00516737 - Study to Test Rizatriptan in the Early Treatment of Acute Migraine (0462-081) | Biotech Hunter | Biotech Hunter